MedTrace Logo

FILtration of Subarachnoid Hemorrhage Via SpinaL CAtheteR Extension

NCT03607825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2022-10-06

Study results available
· View outcomes & findings →

Summary

The objective of this study is to further demonstrate safety and characterize effectiveness of the Neurapheresis™ System (extracorporeal system and catheter) to remove red blood cells (RBCs) and lysed blood by-products from hemorrhagic cerebrospinal fluid (CSF) following aneurysmal subarachnoid hemorrhage (aSAH).

Conditions

  • Subarachnoid Hemorrhage

Interventions

DEVICE

Neurapheresis System

CSF filtration system and lumbar catheter

Sponsors & Collaborators

  • Minnetronix

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-25
Primary Completion
2021-01-11
Completion
2021-02-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03607825 on ClinicalTrials.gov